Clinical Trial Update: Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania [Phase 3]

View source ↗

Summary

A Phase 3 trial in Tanzanian school-aged children assessed the effectiveness and safety of intermittent preventive treatment for malaria using dihydroartemisini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Falciparum Malaria

Drugs mentioned

• Artesunate-amodiaquine (artesunate-amodiaquine)
• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: National Institute for Medical Research, Tanzania | Conditions: Malaria,Falciparum, Anemia | Phase 3 | Status: COMPLETED